Literature DB >> 11462299

Selective arterial distribution of cerebral hyperperfusion in Fabry disease.

D F Moore1, P Herscovitch, R Schiffmann.   

Abstract

Fabry disease is an X-linked recessive deficiency of lysosomal alpha-galactosidase A associated with an increased risk of early onset cerebrovascular disease. The disorder is reported to affect the posterior circulation predominantly. This hypothesis was investigated directly by the measurement of regional cerebral blood flow with positron emission tomography (PET). Resting regional cerebral blood flow (rCBF) in 26 hemizygous patients with Fabry disease and 10 control participants was examined using H(2)15O and PET. Statistical parametric mapping (SPM(t), SPM99) and PET images of patients and controls were produced. Significantly increased SPM(t) clusters were then color coded and blended with a coregistered T1 magnetic resonance imaging (MRI) template. Cerebral arterial territory maps were digitized and rescaled. Custom OpenGL and ImageVision Library C++ code was written to allow a first-order affine transformation of the blended SPM(t) and MRI template onto the arterial territory map. The affine transformation was constrained by choosing corresponding cerebral landmark "tie points" between the SPM(t) [symbol: see text] MRI template images and the cerebral arterial territory maps. The data demonstrated that the posterior circulation is the predominant arterial territory with a significantly increased rCBF in Fabry disease. No arterial distribution had a decreased rCBF.

Entities:  

Mesh:

Year:  2001        PMID: 11462299     DOI: 10.1111/j.1552-6569.2001.tb00051.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  11 in total

1.  Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study.

Authors:  Andreas Fellgiebel; Martin Mazanek; Catharina Whybra; Michael Beck; Ralf Hartung; Kay-Maria Müller; Armin Scheurich; Paulo R Dellani; Peter Stoeter; Matthias J Müller
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

2.  Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling study.

Authors:  Po Phyu; Aine Merwick; Indran Davagnanam; Fay Bolsover; Fatima Jichi; Claudia Wheeler-Kingshott; Xavier Golay; Deralynn Hughes; Lisa Cipolotti; Elaine Murphy; Robin H Lachmann; David John Werring
Journal:  Neurology       Date:  2018-03-21       Impact factor: 9.910

3.  Structural and functional changes in peripheral vasculature of Fabry patients.

Authors:  Riikka J Kalliokoski; Kari K Kalliokoski; Maila Penttinen; Ilkka Kantola; Aila Leino; Jorma S Viikari; Olli Simell; Pirjo Nuutila; Olli T Raitakari
Journal:  J Inherit Metab Dis       Date:  2006-08-12       Impact factor: 4.982

4.  The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease.

Authors:  R J Kalliokoski; I Kantola; K K Kalliokoski; E Engblom; J Sundell; J C Hannukainen; T Janatuinen; O T Raitakari; J Knuuti; M Penttinen; J Viikari; P Nuutila
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

5.  Hearing loss in Fabry disease: the effect of agalsidase alfa replacement therapy.

Authors:  D Hajioff; Y Enever; R Quiney; J Zuckerman; K Mackermot; A Mehta
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

6.  FDG-PET findings in patients with galactosaemia.

Authors:  J G Dubroff; C Ficicioglu; S Segal; N A Wintering; A Alavi; A B Newberg
Journal:  J Inherit Metab Dis       Date:  2008-05-20       Impact factor: 4.982

7.  Fabry disease and early stroke.

Authors:  U Feldt-Rasmussen
Journal:  Stroke Res Treat       Date:  2011-06-23

8.  Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease.

Authors:  David F Moore; Gheona Altarescu; Peter Herscovitch; Raphael Schiffmann
Journal:  BMC Neurol       Date:  2002-06-18       Impact factor: 2.474

9.  Increased arterial diameters in the posterior cerebral circulation in men with Fabry disease.

Authors:  Nurcan Uçeyler; György A Homola; Hans Guerrero González; Daniela Kramer; Christoph Wanner; Frank Weidemann; László Solymosi; Claudia Sommer
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

Review 10.  Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline.

Authors:  Leif Østergaard; Thorbjørn S Engedal; Fiona Moreton; Mikkel B Hansen; Joanna M Wardlaw; Turgay Dalkara; Hugh S Markus; Keith W Muir
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-14       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.